ArticleScientific reports2026
Molecular diversity and evolutionary dynamics of phage receptor binding proteins in Staphylococcus aureus: implications for phage therapy and resistance.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Phage-host interactions are defined by the molecular specificity of receptor-binding proteins (RBPs), which determine the efficacy of infection and the host range. The genetic and structural variability of bacterial receptor molecules is essential for designing effective phage therapeutics and mitigating resistance. This study investigated four receptor-binding proteins, tarS, tarL, tagO, and tagG, in multiple Staphylococcus aureus isolates. Single-nucleotide polymorphism (SNP) analysis was performed to assess receptor diversity and evolutionary conservation. Molecular docking was conducted between these bacterial receptors and Staphylococcus phage tail and spike proteins (TPCARΦ38, TPCARΦ53, TSCARΦ53, and SPCARΦ58) to evaluate binding affinity and interaction specificity. SNP profiling revealed conserved and strain-specific mutations across the receptor genes, predominantly transition-type substitutions, without insertions or deletions. Docking simulations demonstrated strong receptor-phage interactions, with binding energies ranging from 8 to 14 kcal/mol. Despite underlying genetic variation, conserved docking hotspots suggested functional stability and evolutionary pressure to preserve key receptor-binding motifs essential for phage attachment. The findings indicate a coevolutionary balance between S. aureus receptor polymorphism and phage adaptation. Such receptor diversity may drive partial resistance while maintaining susceptibility to related phages. This molecular understanding of RBP evolution provides valuable insights for designing rational, broad-spectrum, or combination phage therapy strategies against S. aureus infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.